Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 62, 2007 - Issue 4
41
Views
26
CrossRef citations to date
0
Altmetric
Original articles

THE DIABETIC FOOT: ESTABLISHED AND EMERGING TREATMENTS

&
Pages 230-238 | Published online: 09 Jan 2014

REFERENCES

  • Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27: 1047–53.
  • Colagiuri S, Borch-Johnsen K, Gliimer C, Vistisen D. There really is an epidemic of type 2 diabetes. Diabetologia. 2005; 48: 1459–63.
  • Boulton AJM. The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia. 2004; 47: 1343–53.
  • Boulton AJ, Vileikyte L, Ragna rson-Tennva El G, Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005; 366:1719–24.
  • Reiber GE, Ledoux WR. Epidemiology of diabetic foot ulcers and complications: evidence for prevention. In: Williams R, Herman W, Kinmoth AL, Wareham NJ (Eds): the evidence basis for dia-betes care. Chichester: Wiley 2002; 641–65.
  • Edmonds M. The diabetic foot, 2003. Diabetes Metab Res Rev. 2004; 20: Su ppl 1: S9–S 12.
  • Papanas N, Maltezos E, Edmonds M. St.Vincent declaration after 15 years of who cleft the devil's foot? Vasa. 2006; 35: 3–4.
  • Bakker K, Foster AVM, van Houtoum WH, Riley P (Eds). Interna-tional Diabetes Federation and International Working Group of the Diabetic Foot. Time to act. The Netherlands, 2005.
  • Jeffcoate WJ, van Houtum WH. Amputation as a marker of the quality of foot care in diabetes. Diabetologia. 2004; 47:2051–8.
  • Bou Eton AJ, Kirsner RS,Vileikyte L. Clinical practice. Neu ropathic diabetic foot ulcers. N Engl I Med. 2004; 351: 48–55.
  • Edmonds ME, Foster AVM, Sanders Li. Stage 3: the ulcerated foot. In: Edmonds ME, Foster AVM, Sanders LJ, A Practical Manual of diabetic footcare, Oxford: Blackwell, 2004,62–101.
  • Low PA. Evaluation of sudomotor function. Clin Neurophysiol. 2004; 115: 1506–13.
  • Jude EB, Oyibo SO, Chalmers N, Boulton AJ. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care. 2001; 24:1433–7.
  • Edmonds ME, Foster AVM, Sanders Li. Stage 4: the infected foot. In: Edmonds ME, Foster AVM, Sanders LJ, A Practical Manual of diabetic footca re, Oxford: Blackwell, 2004, 102–40.
  • Lipsky BA, Berendt AR, Deery HG, et al. Diagnosis and treatment of diabetic foot infections. Plast Reconstr Surg. 2006; 117(7 Suppl): 212S–38S.
  • Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care. 1990; 13:513–21.
  • Prompers L, Huijberts M, Apelqvist J, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Euro-diale study. Diabetologia 2007; 50: 18–25.
  • Frykberg RG, Zgonis T, Armstrong DG, et al. Diabetic foot disor-ders: A clinical practice guideline (2006 revision).J Foot Ankle Surg. 2006; 45:5 Su ppl 1: S1–S66.
  • Shen JT, Falanga V. Innovative therapies in wound healing. J Cutan Med Surg. 2003; 7:217–24.
  • Petrova N, Edmonds M. Emerging drugs for diabetic foot ulcers. Expert Opin Emerg Drugs. 2006; 11: 709–24.
  • Blakytny R, Jude E.The molecular biology of chronic wounds and delayed healing in diabetes. Diabet Med. 2006; 23: 594–608.
  • Sumpio BE, Lee T, Blume PA. Vascular evaluation and arterial reconstruction of the diabetic foot. Clin Podiatr Med Surg. 2003; 20:689–708.
  • Rosenblatt MS, Quist WC, SidawyAN, Paniszyn CC, LoGerfo FW. Results of vein graft reconstruction of the lower extremity in diabetic and nondiabetic patients. Surg Gynecol Obstet. 1990; 171: 331–5.
  • Faglia E, Mantero M, Caminiti M, et al. Extensive use of periphe-ral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects. J intern Med. 2002; 252: 225–32.
  • Faglia E, Dalla Paola L, Clerici G, et al. Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur J Vasc Endovasc Surg. 2005; 29: 620–7.
  • Pomposelli FB, Kansal N, Hamdan AD, et al. A decade of expe-rience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases.J Vasc Surg. 2003; 37: 307–15.
  • Sigala F, Georgopoulos S, Langer S, et al. Outcome of infrain-guinal revascularization for critical limb ischemia in diabetics with end stage renal disease. Vasa. 2006; 35: 15–20.
  • Faglia E, Clerici G, Clerissi J, et al. Early and five-year amputa-tion and survival rate of diabetic patients with critical limb is-chemia: data of a cohort study of 564 patients. Eur J Vasc Endo-vasc Surg. 2006; 32: 484–90.
  • Dormandy JA, Rutherford RB. Management of Peripheral Arte-rial Disease, Trans-Atlantic Inter-Society Consensus (TASC). Eur J Vasc Endovasc Sur. 2000; 19:6: su pp A: S1–S250.
  • Brooks P, Dean R, Patel S, Wu B, Molyneaux L, Yue DK. TBI or not TBI: that is the question. Is it better to measure toe pressure than ankle pressure in diabetic patients? Diabetic Medicine. 2001; 18:528–32.
  • Williams DT, Harding KG, Price P. An evaluation of the efficacy of methods used in screening for lower-limb arterial disease in diabetes. Diabetes Care. 2005; 28: 2206–10.
  • Boulton AJ. Pressure and the diabetic foot: clinical science and offloading techniques. Am J Surg. 2004; 187(5A): 17S-24S. in wound healing. J
  • Armstrong DG, Lavery LA, Wu S, Bou Eton AJ. Evaluation of remo-vable and irremovable cast walkers in the healing of diabetic foot wounds:a randomized controlled trial. Diabetes Care. 2005; 28: 551–4.
  • Steed DL, Donohoe D, Webster MW, Lindsley L. Effect of exten-sive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group. J Am Coll Surg. 1996; 183: 61–4.
  • Steed DL. Debridement. Am J Surg. 2004; 187: 71S–4S.
  • Gwynne B, Newton M. An overview of the common methods of wound debridement. Br J Nurs. 2006; 15: S4–S10.
  • Armstrong DG, Lavery LA; Diabetic Foot Study Consortium. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet. 2005; 366: 1704–10.
  • Andros G, Armstrong DG, Attinger CE et al. Consensus statement on negative pressure wound therapy (V.A.C. Therapy) for the management of diabetic foot wounds. Ostomy Wound Manage. 2006; Suppl:1–32.
  • Rauwerda JA. Surgical treatment of the infected diabetic foot. Diabetes Metab Res Rev. 2004; 20 Suppl 1: S41–4.
  • Edmonds ME, Van Acker K, Foster AV. Education and the diabetic foot. Diabet Med. 1996; 13 Suppl 1:S61–4.
  • Papanas N, Maltezos E, Edmonds M. The diabetic foot: a plea for the elementary? Acta Diabetol. 2006; 43: 152–3.
  • Brookes S, O'Leary B. Feet first:a guide to diabetic foot services. Br J Nurs. 2006; 15: S4–10.
  • Valk GD, Kriegsman DM, Assendelft WJ. Patient education for preventing diabetic foot ulceration. Cochrane Database Syst Rev. 2005; 1: CD001488.
  • Abu-Qamar MZ. Diabetic foot screening: why is it neglected? Int Wound J. 2006; 3:203–13.
  • van Houtum W. Barriers to the delivery of diabetic foot care. Lancet. 2005; 366: 1678–9.
  • van Gils CC, Stark LA. Diabetes mellitus and the elderly: special considerations for foot ulcer prevention and care. Ostomy Wound Manage. 2006; 52: 50–2.
  • Lawrence A. Foot care education in renal patients with diabetes. EDTNA ERCA J. 2004; 30: 153–6.
  • Kiely CI, Crestodina L. Diabetic foot care education: it's not just about the foot.J Wound Ostomy Continence Nurse. 2006; 33: 416–21.
  • Papanas N, Edmonds A, Maltezos E, Edmonds M. The Ten Com-mandments of the diabetic foot. BMJ. 2005; 331: 1497.
  • Armstrong DG. Is diabetic foot care efficacious or cost effective? Ostomy Wound Manage. 2001; 47: 28–32.
  • Edmonds M. Diabetic foot ulcers: practical treatment recom-mendations. Drugs. 2006; 66: 913–29.
  • Viswanathan V, Madhavan S, Gnanasundaram S et al. Effective-ness of different types of footwear insoles for the diabetic neuropathic foot: a follow-up study. Diabetes Care. 2004; 27: 474–7.
  • Edmonds ME, Blundell MP, Morris ME, Thomas EM, Cotton LT, Watkins PJ. Improved survival of the diabetic foot: the role of a specialized foot clinic. QJ Med. 1986; 60: 763–71.
  • Holstein PE, Sorensen S. Limb salvage experience in a multidis-ciplinary diabetic foot unit. Diabetes Care. 1999; 22 Suppl 2: B97–103.
  • Holstein P, Ellitsgaard N, Olsen BB, Ellitsgaard V. Decreasing incidence of major amputations in people with diabetes. Dia-betologia. 2000; 43: 844–7.
  • van Houtum WH, Rauwerda JA, Ruwaard D, Schaper NC, Bakker K. Reduction in diabetes-related lower-extremity amputations in The Netherlands: 1991-2000. Diabetes Care. 2004; 27: 1042–6.
  • Foster AV, Snowden S, Grenfell A, Watkins PJ, Edmonds ME. Re-duction of gangrene and amputations in diabetic renal transplant patients: the role of a special foot clinic. Diabet Med. 1995; 12: 632–5.
  • El Sakka K, Fassiadis N, Gambhir RP et al. An integrated care pathway to save the critically ischaemic diabetic foot. Intl Clin Pract. 2006; 60: 667–9.
  • Lavery LA, van Houtum WH, Ashry HR, Armstrong DG, Pugh JA. Diabetes-related lower-extremity amputations disproportiona-tely affect Blacks and Mexican Americans. South Med J. 1999; 92: 593–9.
  • Pedrosa HC, Leme LAP, Novaes C et al. The diabetic foot in South America: progress with the save the diabetic foot project. International Diabetes Monitor. 2004; 16: 17–24.
  • Van Acker K, Weyler J, De Leeuw I. The Diabetic Foot Project of Flanders, the northern part of Belgium: implementation of the St Vincent consensus. Sensibilisation and registration in diabe-tes centres. Acta Clin Belg. 2001; 56: 21–31.
  • Papanas N. Maltezos E. Growth factors in the treatment of dia-betic foot ulcers: New technologies, any promises? Int J Lower Extrem Wounds. 2007; 6: 37–53.
  • Steed DL. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers. Plast Reconstr Surg. 2006; 117 (7 Suppl): 143S–9S.
  • Tarzami ST, Singh JP. Pharmacological revascularisation in coro-nary and peripheral vascular disease. Expert Opin Invest Drugs. 2004; 13:1319–26.
  • Edmonds M, Bates M, Doxford M, Gough A, Foster A. New treat-ments in ulcer healing and wound infection. Diabetes Metab Res Rev. 2000; 16 Suppl 1:S51–4.
  • Berendt AR. Counterpoint: hyperbaric oxygen for diabetic foot wounds is not effective. Clin Infect Dis. 2006; 43: 193–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.